153710 Stock Chart & Stats
₩4480.00
-₩75.00(-1.65%)
―
--
Day’s Range― - ―
52-Week Range₩4,075.00 - ₩6,250.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)10.57K
Market Cap
₩66.82B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.16
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding14,669,958
10 Day Avg. Volume12,917
30 Day Avg. Volume10,575
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
153710 FAQ
What was Optipharm Co., Ltd.’s price range in the past 12 months?
Optipharm Co., Ltd. lowest stock price was ₩4075.00 and its highest was ₩6250.00 in the past 12 months.
What is Optipharm Co., Ltd.’s market cap?
Optipharm Co., Ltd.’s market cap is ₩66.82B.
When is Optipharm Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Optipharm Co., Ltd.’s earnings last quarter?
Optipharm Co., Ltd. released its earnings results on May 15, 2026. The company reported -₩51.391 earnings per share for the quarter, missing the consensus estimate of N/A by -₩51.391.
Is Optipharm Co., Ltd. overvalued?
According to Wall Street analysts Optipharm Co., Ltd.’s price is currently Undervalued.
Does Optipharm Co., Ltd. pay dividends?
Optipharm Co., Ltd. does not currently pay dividends.
What is Optipharm Co., Ltd.’s EPS estimate?
Optipharm Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Optipharm Co., Ltd. have?
Optipharm Co., Ltd. has 14,669,958 shares outstanding.
What happened to Optipharm Co., Ltd.’s price movement after its last earnings report?
Optipharm Co., Ltd. reported an EPS of -₩51.391 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.101%.
Which hedge fund is a major shareholder of Optipharm Co., Ltd.?
Currently, no hedge funds are holding shares in KR:153710
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Polaris AI Pharma Corp.
―
iNtRON Biotechnology, Inc.
―
Daehan Nupharm Co., Ltd.
―
CKD Bio Corp.
―
CytoGen, Inc.
―